BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37718554)

  • 1. Intermittently scanned continuous glucose monitoring and hypoglycaemia awareness in drivers with diabetes: Insights from the Association of British Clinical Diabetologists Nationwide audit.
    Mark-Wagstaff C; Deshmukh H; Wilmot EG; Walker N; Barnes D; Parfitt V; Saunders S; Gregory R; Choudhary P; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabetes Obes Metab; 2024 Jan; 26(1):46-53. PubMed ID: 37718554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term impact of glucose monitoring with the FreeStyle Libre on glycaemic control and hypoglycaemia awareness in people with type 1 diabetes: Insights from the Association of British Clinical Diabetologists national audit.
    Shah N; Deshmukh H; Wilmot EG; Patmore J; Christian P; Barnes DJ; Walton C; Ryder REJ; Sathyapalan T
    Diabet Med; 2023 Jun; 40(6):e15070. PubMed ID: 36797537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.
    Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabetes Care; 2020 Sep; 43(9):2153-2160. PubMed ID: 32669277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time in range following flash glucose monitoring: Relationship with glycaemic control, diabetes-related distress and resource utilisation in the Association of British Clinical Diabetologists national audit.
    Deshmukh H; Wilmot E; Pieri B; Choudhary P; Shah N; Gregory R; Kilvert A; Lumb A; Christian P; Barnes D; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabet Med; 2022 Nov; 39(11):e14942. PubMed ID: 36054655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of diabetes-related distress before and after FreeStyle Libre-1 use: Lessons from the Association of British Clinical Diabetologists nationwide study.
    Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabetes Obes Metab; 2021 Oct; 23(10):2261-2268. PubMed ID: 34142425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia.
    Charleer S; De Block C; Bolsens N; Van Huffel L; Nobels F; Mathieu C; Gillard P
    Diabetes Technol Ther; 2023 Apr; 25(4):231-241. PubMed ID: 36648249
    [No Abstract]   [Full Text] [Related]  

  • 8. Self-reported non-severe hypoglycaemic events in Europe.
    Östenson CG; Geelhoed-Duijvestijn P; Lahtela J; Weitgasser R; Markert Jensen M; Pedersen-Bjergaard U
    Diabet Med; 2014 Jan; 31(1):92-101. PubMed ID: 23796113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycaemia and driving in people with insulin-treated diabetes: adherence to recommendations for avoidance.
    Graveling AJ; Warren RE; Frier BM
    Diabet Med; 2004 Sep; 21(9):1014-9. PubMed ID: 15317607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of new European Union driving regulations on patients with Type 1 diabetes who participated in the Diabetes Control and Complications Trial.
    Kilpatrick ES; Rigby AS; Warren RE; Atkin SL
    Diabet Med; 2013 May; 30(5):616-9. PubMed ID: 23215789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia.
    Davis TME; Dwyer P; England M; Fegan PG; Davis WA
    Diabetes Technol Ther; 2020 May; 22(5):367-373. PubMed ID: 31724878
    [No Abstract]   [Full Text] [Related]  

  • 13. Real-time continuous glucose monitoring as a tool to prevent severe hypoglycaemia in selected pregnant women with Type 1 diabetes - an observational study.
    Secher AL; Stage E; Ringholm L; Barfred C; Damm P; Mathiesen ER
    Diabet Med; 2014 Mar; 31(3):352-6. PubMed ID: 24341466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prepregnancy care in women with type 1 diabetes improves HbA
    Perea V; Giménez M; Amor AJ; Bellart J; Conget I; Vinagre I
    Diabetes Res Clin Pract; 2019 Aug; 154():75-81. PubMed ID: 31271810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and driving.
    Inkster B; Frier BM
    Diabetes Obes Metab; 2013 Sep; 15(9):775-83. PubMed ID: 23350766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study.
    Charleer S; De Block C; Van Huffel L; Broos B; Fieuws S; Nobels F; Mathieu C; Gillard P
    Diabetes Care; 2020 Feb; 43(2):389-397. PubMed ID: 31843948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycaemia and its management in primary care setting.
    Ibrahim M; Baker J; Cahn A; Eckel RH; El Sayed NA; Fischl AH; Gaede P; Leslie RD; Pieralice S; Tuccinardi D; Pozzilli P; Richelsen B; Roitman E; Standl E; Toledano Y; Tuomilehto J; Weber SL; Umpierrez GE
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3332. PubMed ID: 32343474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and protocol for the Assessment of Impact of Real-time Continuous Glucose Monitoring on people presenting with severe Hypoglycaemia (AIR-CGM) study.
    Avari P; Ramli R; Reddy M; Oliver N; Fothergill R
    BMC Endocr Disord; 2019 Oct; 19(1):110. PubMed ID: 31655586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions.
    Amiel SA; Choudhary P; Jacob P; Smith EL; De Zoysa N; Gonder-Frederick L; Kendall M; Heller S; Brooks A; Toschi E; Kariyawasam D; Potts L; Healy A; Rogers H; Sevdalis N; Stadler M; Qayyum M; Bakolis I; Goldsmith K
    BMJ Open; 2019 Jun; 9(6):e030356. PubMed ID: 31209097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.